HIN heartware international, inc

the possible game changer

  1. 2,117 Posts.
    lightbulb Created with Sketch. 319

    of 618





    HTWR gives $149k Grant to Clev-Clin. researcher K.Fukamachi for MVAD studies. (not sure when it was awarded - newsletter dated Dec. 2012)...

    Kiyotaka Fukamachi, MD, PhD, Biomedical Engineering, received a 1-year, $149K award from HeartWare, Inc. (Framingham, MA), for "Acute evaluation of HeartWare MVAD in a pacing-induced heart failure model in sheep." Nader Moazami, MD, Thoracic and Cardiovascular Surgery, is a co-investigator on the study.

    This research evaluates the performance of a miniaturized left ventricular assist device (about one third the size of the company's device for humans) in an animal model. The tiny device may one day allow surgeons to implant it under minimally invasive procedures in people, avoiding the risks to the patient of full "rib-cracking" (median sternotomy) surgery.

    Interesting!!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.